Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-09-05 | New | $7,000,000 | Unknown | Equity Only | SEC link | |
| 2024-05-31 | New | $15,150,007 | $15,150,007 | Equity Only | 06b | SEC link |
| 2024-05-31 | New | $26,850,006 | $26,850,006 | Equity Only | 06b | SEC link |
| 2022-08-30 | New | $0 | $0 | Other | 06b | SEC link |
| 2020-11-24 | New | $18,067,000 | $18,067,000 | Equity Only | 06b | SEC link |
| 2020-08-11 | New | $0 | $0 | Equity Only | 06b | SEC link |
| 2020-05-21 | New | $482,498 | $482,498 | Other | 06b | SEC link |
| 2020-04-14 | New | $459,998 | $459,998 | Other | 06b | SEC link |
| 2020-04-07 | New | $1,233,057 | $1,233,057 | Equity Only | 06b | SEC link |
| 2017-04-13 | New | $2,027,760 | $2,027,760 | Equity Only | 06b | SEC link |
| 2007-02-02 | Paper Filing | Unknown | Unknown | Other | Not Available | |
| 2005-03-23 | Paper Filing | Unknown | Unknown | Other | Not Available |
| Name | Role |
|---|---|
| Raymond Akers | Director, Executive |
| Robert E. Andrews | Director |
| Stuart Benson | Executive |
| Bruce Bernstein | Director |
| Raza Bokhari | Director |
| Chris Chapman | Executive |
| Craig Eagle | Director |
| Stephen Friscia | Director |
| Mitchell Glass | Director, Executive |
| John Gormally | Executive |
| Adam Kaplin | Executive |
| Thomas Knox | Director |
| Brandon Knox | Director |
| Gary Rauch | Executive |
| Ian Rhodes | Executive |
| Paul Rivard | Executive |
| Christopher Schreiber | Director |
| Robert C. Schroeder | Director |
| Joshua Silverman | Director, Executive |
| Jude Uzonwanne | Director |
| Bill J. White | Director |
| Howard Yeaton | Executive |